Learn More
Apexbio Technology LLC Clinafloxacin CI96 AM1091 105956-97-6 250mg

Supplier: Apexbio Technology LLC A8400250
Clinafloxacin CI96 AM1091 (CAS 105956-97-6) is a small-molecule inhibitor targeting bacterial DNA gyrase and topoisomerase IV It is designed to inhibit these type II topoisomerases thereby disrupting bacterial DNA replication and transcription Clinafloxacin CI96 AM1091 exerts its biological activity primarily through dual inhibition of DNA gyrase and topoisomerase IV In enzymatic assays against Staphylococcus aureus clinafloxacin demonstrates inhibitory activity with IC50 values of 0 92 g/mL for DNA gyrase and 1 62 g/mL for topoisomerase IV Based on these pharmacological properties clinafloxacin CI96 AM1091 holds research potential in bacteriology studies of bacterial resistance mechanisms and evaluation of drug-resistant bacterial strains
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.